Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging

• Jae Hyun Kim,

  Affiliation Department of Radiology, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Seung Hong Choi ,

  * E-mail: verocay@snuh.org

  Affiliations Department of Radiology, Seoul National University College of Medicine, Seoul, Korea, Center for Nanoparticle Research, Institute for Basic Science, and School of Chemical and Biological Engineering, Seoul National University, Seoul, Korea

  ⨯
• Inseon Ryoo,

  Affiliation Department of Radiology, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Tae Jin Yun,

  Affiliation Department of Radiology, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Tae Min Kim,

  Affiliation Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Se-Hoon Lee,

  Affiliation Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Chul-Kee Park,

  Affiliation Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Ji-Hoon Kim,

  Affiliation Department of Radiology, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Chul-Ho Sohn,

  Affiliation Department of Radiology, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Sung-Hye Park,

  Affiliation Department of Pathology, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Il Han Kim

  Affiliation Department of Radiation Oncology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

  ⨯